Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): soluble CD134 activates FIV Env for CXCR4-dependent entry and reveals a cryptic neutralization epitope.
about
Pharmacological inhibition of feline immunodeficiency virus (FIV)Could FIV zoonosis responsible of the breakdown of the pathocenosis which has reduced the European CCR5-Delta32 allele frequenciesUnliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loopsGoing wild: lessons from naturally occurring T-lymphotropic lentivirusesFIV cross-species transmission: an evolutionary prospective.Fine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein.Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV.Mapping the domains of CD134 as a functional receptor for feline immunodeficiency virus.Feline immunodeficiency virus (FIV) neutralization: a reviewAntibodies generated in cats by a lipopeptide reproducing the membrane-proximal external region of the feline immunodeficiency virus transmembrane enhance virus infectivity.Mapping of Receptor Binding Interactions with the FIV surface Glycoprotein (SU); Implications Regarding Immune surveillance and cellular Targets of Infection.Molecular mechanisms of FIV infection.Mapping of the CXCR4 binding site within variable region 3 of the feline immunodeficiency virus surface glycoprotein.A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction.Enforced covalent trimerisation of soluble feline CD134 (OX40)-ligand generates a functional antagonist of feline immunodeficiency virus.Domestic cat microsphere immunoassays: detection of antibodies during feline immunodeficiency virus infectionImproved health and survival of FIV-infected cats is associated with the presence of autoantibodies to the primary receptor, CD134.Replacement of the V3 domain in the surface subunit of the feline immunodeficiency virus envelope glycoprotein with the equivalent region of a T cell-tropic human immunodeficiency virus type 1 results in a chimeric surface protein that efficiently bMutations in the feline immunodeficiency virus envelope glycoprotein confer resistance to a dominant-negative fragment of Tsg101 by enhancing infectivity and cell-to-cell virus transmission.The molecular biology of feline immunodeficiency virus (FIV).Sequence variation of the feline immunodeficiency virus genome and its clinical relevance.Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibodyEmergence of CD134 cysteine-rich domain 2 (CRD2)-independent strains of feline immunodeficiency virus (FIV) is associated with disease progression in naturally infected cats.CD4+CD25+ regulatory T cells are infected and activated during acute FIV infection.Applications of the FIV Model to Study HIV Pathogenesis.FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge.
P2860
Q26995310-38187923-FDF6-4020-AC4E-8E993BA40CB6Q27487233-600C8CB3-1F1E-41BC-91A0-0A4803F8397DQ27678226-88A584FA-7F5B-43D9-8E0A-B706AD2FCC21Q31066870-DD20C1D2-CACF-448B-95C1-2E129079CAA9Q31147670-18F35DA0-EACC-4F2B-8B25-497EDB805756Q33587317-523C5192-EFC5-4F3B-9B5B-034AF185BA1FQ33786404-8C70891F-3560-4F25-8CD5-5B98A209A691Q35023787-A9D23775-EB84-4D10-B270-BF770D2A3913Q35491705-0A102D9C-CB95-42C2-BE1B-9D32A6E90B64Q36097111-3DE65724-6378-4A99-B102-65EC21839557Q36470890-232EE659-FD94-4122-ACDE-643C7F96ABC4Q36692802-60C564F5-FD49-4374-B955-0C316CFFD16AQ36898649-4BBBD374-99FF-4E66-93EA-B0166BFE2FFFQ36926701-4549EDFB-7BC4-4FE5-AD6E-1DA383B6A990Q37177498-6DD0E4D3-6C8F-43F5-9B00-3C27B8C5C2F0Q37295135-931256F4-D7DB-4437-B30B-9F42CAE835B8Q37415950-36D7CC60-573D-4F5C-85B9-F34A65E361A9Q37610630-90D45F5F-0B78-4DEB-B882-78FA1637042AQ37619606-15377400-9F90-487C-83D7-E319A813AE03Q37967732-5D988C7A-25AD-4CE2-9E72-77231C36E0B4Q38113162-86483234-BFA1-4622-9251-BA7B076146BAQ40653669-EE510AD4-DA41-4287-9C55-6BD1F36D8CCDQ41645414-7FA00D10-B2DC-48B2-8F83-1274A6EF0038Q43225104-DCAAEDA7-32AD-494D-9100-BADA54F49349Q52574472-26E084E1-6591-4A55-8A13-9EF52F3EA38FQ53686365-815EBE1D-BDDE-48D9-8BFF-B598D2794E98
P2860
Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): soluble CD134 activates FIV Env for CXCR4-dependent entry and reveals a cryptic neutralization epitope.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Sequential CD134-CXCR4 interac ...... ryptic neutralization epitope.
@ast
Sequential CD134-CXCR4 interac ...... ryptic neutralization epitope.
@en
Sequential CD134-CXCR4 interactions in feline immunodeficiency virus
@nl
type
label
Sequential CD134-CXCR4 interac ...... ryptic neutralization epitope.
@ast
Sequential CD134-CXCR4 interac ...... ryptic neutralization epitope.
@en
Sequential CD134-CXCR4 interactions in feline immunodeficiency virus
@nl
prefLabel
Sequential CD134-CXCR4 interac ...... ryptic neutralization epitope.
@ast
Sequential CD134-CXCR4 interac ...... ryptic neutralization epitope.
@en
Sequential CD134-CXCR4 interactions in feline immunodeficiency virus
@nl
P2093
P2860
P1433
P1476
Sequential CD134-CXCR4 interac ...... cryptic neutralization epitope
@en
P2093
Aymeric de Parseval
Chris K Grant
John H Elder
P2860
P304
P356
10.1128/JVI.80.6.3088-3091.2006
P407
P50
P577
2006-03-01T00:00:00Z